|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PXMP2-SLC44A2 (FusionGDB2 ID:70461) |
Fusion Gene Summary for PXMP2-SLC44A2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: PXMP2-SLC44A2 | Fusion gene ID: 70461 | Hgene | Tgene | Gene symbol | PXMP2 | SLC44A2 | Gene ID | 5827 | 57153 |
Gene name | peroxisomal membrane protein 2 | solute carrier family 44 member 2 | |
Synonyms | MPV17L3|PMP22 | CTL2|PP1292 | |
Cytomap | 12q24.33 | 19p13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | peroxisomal membrane protein 222 kDa peroxisomal membrane proteinperoxisomal membrane protein 2, 22kDa | choline transporter-like protein 2solute carrier family 44 (choline transporter), member 2testicular tissue protein Li 47 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000317479, ENST00000543589, ENST00000545677, ENST00000539093, ENST00000428960, | ENST00000407327, ENST00000335757, ENST00000586078, ENST00000588214, | |
Fusion gene scores | * DoF score | 8 X 4 X 5=160 | 10 X 11 X 8=880 |
# samples | 8 | 20 | |
** MAII score | log2(8/160*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(20/880*10)=-2.13750352374993 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PXMP2 [Title/Abstract] AND SLC44A2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PXMP2(133277955)-SLC44A2(10746999), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | PXMP2-SLC44A2 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. PXMP2-SLC44A2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | SLC44A2 | GO:0015871 | choline transport | 20410607 |
Tgene | SLC44A2 | GO:0055085 | transmembrane transport | 20410607 |
Fusion gene breakpoints across PXMP2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SLC44A2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | GBM | TCGA-27-2524-01A | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
Top |
Fusion Gene ORF analysis for PXMP2-SLC44A2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000317479 | ENST00000407327 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
In-frame | ENST00000317479 | ENST00000335757 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
In-frame | ENST00000317479 | ENST00000586078 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
5CDS-intron | ENST00000317479 | ENST00000588214 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
intron-3CDS | ENST00000543589 | ENST00000407327 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
intron-3CDS | ENST00000543589 | ENST00000335757 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
intron-3CDS | ENST00000543589 | ENST00000586078 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
intron-intron | ENST00000543589 | ENST00000588214 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
Frame-shift | ENST00000545677 | ENST00000407327 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
Frame-shift | ENST00000545677 | ENST00000335757 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
Frame-shift | ENST00000545677 | ENST00000586078 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
5CDS-intron | ENST00000545677 | ENST00000588214 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
Frame-shift | ENST00000539093 | ENST00000407327 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
Frame-shift | ENST00000539093 | ENST00000335757 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
Frame-shift | ENST00000539093 | ENST00000586078 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
5CDS-intron | ENST00000539093 | ENST00000588214 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
In-frame | ENST00000428960 | ENST00000407327 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
In-frame | ENST00000428960 | ENST00000335757 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
In-frame | ENST00000428960 | ENST00000586078 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
5CDS-intron | ENST00000428960 | ENST00000588214 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000317479 | PXMP2 | chr12 | 133277955 | + | ENST00000407327 | SLC44A2 | chr19 | 10746999 | + | 2637 | 584 | 20 | 1471 | 483 |
ENST00000317479 | PXMP2 | chr12 | 133277955 | + | ENST00000335757 | SLC44A2 | chr19 | 10746999 | + | 2646 | 584 | 20 | 1471 | 483 |
ENST00000317479 | PXMP2 | chr12 | 133277955 | + | ENST00000586078 | SLC44A2 | chr19 | 10746999 | + | 3026 | 584 | 20 | 1486 | 488 |
ENST00000428960 | PXMP2 | chr12 | 133277955 | + | ENST00000407327 | SLC44A2 | chr19 | 10746999 | + | 2399 | 346 | 25 | 1233 | 402 |
ENST00000428960 | PXMP2 | chr12 | 133277955 | + | ENST00000335757 | SLC44A2 | chr19 | 10746999 | + | 2408 | 346 | 25 | 1233 | 402 |
ENST00000428960 | PXMP2 | chr12 | 133277955 | + | ENST00000586078 | SLC44A2 | chr19 | 10746999 | + | 2788 | 346 | 25 | 1248 | 407 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000317479 | ENST00000407327 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + | 0.008547677 | 0.99145234 |
ENST00000317479 | ENST00000335757 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + | 0.008170959 | 0.991829 |
ENST00000317479 | ENST00000586078 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + | 0.006577123 | 0.9934229 |
ENST00000428960 | ENST00000407327 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + | 0.012384952 | 0.9876151 |
ENST00000428960 | ENST00000335757 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + | 0.011829765 | 0.98817027 |
ENST00000428960 | ENST00000586078 | PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746999 | + | 0.010397603 | 0.9896024 |
Top |
Fusion Genomic Features for PXMP2-SLC44A2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746998 | + | 7.51E-13 | 1 |
PXMP2 | chr12 | 133277955 | + | SLC44A2 | chr19 | 10746998 | + | 7.51E-13 | 1 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PXMP2-SLC44A2 |
Go to FGviewer for the breakpoints of chr12:133277955-chr19:10746999 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PXMP2 | chr12:133277955 | chr19:10746999 | ENST00000317479 | + | 4 | 5 | 136_173 | 173.0 | 196.0 | Topological domain | Peroxisomal |
Hgene | PXMP2 | chr12:133277955 | chr19:10746999 | ENST00000317479 | + | 4 | 5 | 1_30 | 173.0 | 196.0 | Topological domain | Cytoplasmic |
Hgene | PXMP2 | chr12:133277955 | chr19:10746999 | ENST00000317479 | + | 4 | 5 | 52_75 | 173.0 | 196.0 | Topological domain | Peroxisomal |
Hgene | PXMP2 | chr12:133277955 | chr19:10746999 | ENST00000317479 | + | 4 | 5 | 97_114 | 173.0 | 196.0 | Topological domain | Cytoplasmic |
Hgene | PXMP2 | chr12:133277955 | chr19:10746999 | ENST00000317479 | + | 4 | 5 | 115_135 | 173.0 | 196.0 | Transmembrane | Helical |
Hgene | PXMP2 | chr12:133277955 | chr19:10746999 | ENST00000317479 | + | 4 | 5 | 31_51 | 173.0 | 196.0 | Transmembrane | Helical |
Hgene | PXMP2 | chr12:133277955 | chr19:10746999 | ENST00000317479 | + | 4 | 5 | 76_96 | 173.0 | 196.0 | Transmembrane | Helical |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 481_504 | 411.0 | 707.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 526_563 | 411.0 | 707.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 585_599 | 411.0 | 707.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 621_638 | 411.0 | 707.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 660_706 | 411.0 | 707.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 481_504 | 409.0 | 705.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 526_563 | 409.0 | 705.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 585_599 | 409.0 | 705.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 621_638 | 409.0 | 705.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 660_706 | 409.0 | 705.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 481_504 | 411.0 | 712.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 526_563 | 411.0 | 712.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 585_599 | 411.0 | 712.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 621_638 | 411.0 | 712.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 660_706 | 411.0 | 712.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 458_480 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 505_525 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 564_584 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 600_620 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 639_659 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 458_480 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 505_525 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 564_584 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 600_620 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 639_659 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 458_480 | 411.0 | 712.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 505_525 | 411.0 | 712.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 564_584 | 411.0 | 712.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 600_620 | 411.0 | 712.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 639_659 | 411.0 | 712.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PXMP2 | chr12:133277955 | chr19:10746999 | ENST00000317479 | + | 4 | 5 | 174_194 | 173.0 | 196.0 | Transmembrane | Helical |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 1_33 | 411.0 | 707.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 254_256 | 411.0 | 707.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 278_315 | 411.0 | 707.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 337_364 | 411.0 | 707.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 386_457 | 411.0 | 707.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 55_232 | 411.0 | 707.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 1_33 | 409.0 | 705.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 254_256 | 409.0 | 705.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 278_315 | 409.0 | 705.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 337_364 | 409.0 | 705.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 386_457 | 409.0 | 705.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 55_232 | 409.0 | 705.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 1_33 | 411.0 | 712.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 254_256 | 411.0 | 712.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 278_315 | 411.0 | 712.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 337_364 | 411.0 | 712.0 | Topological domain | Cytoplasmic | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 386_457 | 411.0 | 712.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 55_232 | 411.0 | 712.0 | Topological domain | Extracellular | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 233_253 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 257_277 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 316_336 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 34_54 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000335757 | 13 | 22 | 365_385 | 411.0 | 707.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 233_253 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 257_277 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 316_336 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 34_54 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000407327 | 13 | 22 | 365_385 | 409.0 | 705.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 233_253 | 411.0 | 712.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 257_277 | 411.0 | 712.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 316_336 | 411.0 | 712.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 34_54 | 411.0 | 712.0 | Transmembrane | Helical | |
Tgene | SLC44A2 | chr12:133277955 | chr19:10746999 | ENST00000586078 | 13 | 22 | 365_385 | 411.0 | 712.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for PXMP2-SLC44A2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000317479_ENST00000407327_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(transcript)=2637nt_BP=584nt GGGCTCCGCGCCCGGCCAGCCTGAGGTGGGGTCGGTGCCCCCGGCGGCACGGCGCTGGGGAGGCGATGGCGCCGGCCGCGTCCAGGCTGC GGGCCGAAGCCGGGCTCGGGGCGCTGCCGCGGCGGGCGCTCGCCCAGTACCTGCTCTTCCTGCGGCTCTACCCGGTGCTCACCAAGGCGG CCACCAGTGGCATTTTGTCAGCACTTGGGAACTTCCTGGCCCAGATGATTGAGAAGAAGCGGAAAAAAGAAAACTCTAGAAGTCTGGATG TCGGTGGGCCTCTGAGATATGCCGTTTACGGGTTCTTCTTCACAGGGCCGCTGAGTCACTTCTTCTACTTCTTCATGGAACATTGGATCC CTCCTGAGGTCCCCCTGGCAGGGCTCAGGAGGCTTCTCCTGGACCGCCTCGTCTTTGCACCGGCCTTCCTCATGTTGTTCTTCCTCATCA TGAACTTTCTGGAGGGGAAAGACGCCTCAGCCTTCGCCGCCAAGATGAGGGGGGGCTTCTGGCCGGCGCTGAGGATGAACTGGCGGGTGT GGACGCCACTACAGTTCATCAACATCAACTACGTCCCTCTGAAGACCTTCCCCTCCTCCAATGAGTCCCGCCAATGCCCCAATGCCCGTT GCCAGTTCGCCTTCTACGGTGGTGAGTCGGGCTACCACCGGGCCCTGCTGGGCCTGCAGATCTTCAATGCCTTCATGTTCTTCTGGTTGG CCAACTTCGTGCTGGCGCTGGGCCAGGTCACGCTGGCCGGGGCCTTTGCCTCCTACTACTGGGCCCTGCGCAAGCCGGACGACCTGCCGG CCTTCCCGCTCTTCTCTGCCTTTGGCCGGGCGCTCAGGTACCACACAGGCTCCCTGGCCTTTGGCGCGCTCATCCTGGCCATTGTGCAGA TCATCCGTGTGATACTCGAGTACCTGGATCAGCGGCTGAAAGCTGCAGAGAACAAGTTTGCCAAGTGCCTCATGACCTGTCTCAAATGCT GCTTCTGGTGCCTGGAGAAGTTCATCAAATTCCTTAATAGGAATGCCTACATCATGATTGCCATCTACGGCACCAATTTCTGCACCTCGG CCAGGAATGCCTTCTTCCTGCTCATGAGAAACATCATCAGAGTGGCTGTCCTGGATAAAGTTACTGACTTCCTCTTCCTGTTGGGCAAAC TTCTGATCGTTGGTAGTGTGGGGATCCTGGCTTTCTTCTTCTTCACCCACCGTATCAGGATCGTGCAGGATACAGCACCACCCCTCAATT ATTACTGGGTTCCTATACTGACGGTGATCGTTGGCTCCTACTTGATTGCACACGGTTTCTTCAGCGTCTATGGCATGTGTGTGGACACGC TGTTCCTCTGCTTCTTGGAGGACCTGGAGAGGAATGACGGCTCGGCCGAGAGGCCTTACTTCATGTCTTCCACCCTCAAGAAACTCTTGA ACAAGACCAACAAGAAGGCAGCGGAGTCCTGAAGGCCCCGTGCTCCCCACCTCTCAAGGAGTCTCATGCCGCAGGGTGCTCAGTAGCTGG GTCTGTTCCCCCAGCCCCTTGGGCTCACCTGAAGTCCTATCACTGCCGCTCTGCCCCTCCCCATGAGCCAGATCCCACCAGTTTCTGGAC GTGGAGAGTCTGGGGCATCTCCTTCTTATGCCAAGGGGCGCTTGGAGTTTTCATGGCTGCCCCTCCAGACTGCGAGAAACAAGTAAAAAC CCATTGGGGCCTCTTGATGTCTGGGATGGCACGTGGCCCGACCTCCACAAGCTCCCTCATGCTTCCTGTCCCCCGCTTACACGACAACGG GCCAGACCACAGGAAGGACGGTGTTTGTGTCTGAGGGAGCTGCTGGCCACAGTGAACACCCACGTTTATTCCTGCCTGCTCCGGCCAGGA CTGAACCCCTTCTCCACACCTGAACAGTTGGCTCAAGGGCCACCAGAAGCATTTCTTTATTATTATTATTTTTTAACCTGGACATGCATT AAAGGGTCTATTAGCTTTCTTTCCGTCTGTCTCAACAGCTGAGATGGGGCCGCCAAGGAGTGCCTTCCTTTTGCTCCCTCCTAGCTGGGA GTGACGGGTGGGAGTGTGTGTGCCCAGGTGGGGGTGTCTCCTGGCTGGGAAGGAGGGAAAGGGAGGGAGAGTTTTGCGGGGGTTGGCAGT GGAGAGCAGGCTGGAGAGGAGATGGCTAATAGCTGTTTAATGGAAACCTGCTGGGCTGGAGGGAGTTAGGCTGAATTTCCCGACTTCCTC TGCCAGTTATTGACACAGCTCTCTTTGTAAGAGAGGAAAGAAACTAAACCCACCCAAGGGATGATGTCAGGGGGAGAGGTGGAGGGCAGA TGTCCTGGGCAAACCGGGCCCCTCTGCCCACACACCTCACTTGATCCTTTTGCCAAACTTGTCAAACTCAGGGGAACTGGCTTCCCAGTT GCCCCTTTGCCATATTCCAAGTCCCCCTCAGACTTCATGTCTCTGCTCATCAGCACTGTCCCAGGATCCTGGAGAGGGAGAACTCCTGGC CCCAGGGGAAAGAGGGGGGGGTCTCCCGTTTCCTGTGCCTGCACCAGCCCTGCCCCCATTGCGTCTGCACACCCCTGCGTGTAACTGCAT >In-frame_ENST00000317479_ENST00000407327_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(amino acids)=483AA_start in transcript=20_stop in transcript=1471 MRWGRCPRRHGAGEAMAPAASRLRAEAGLGALPRRALAQYLLFLRLYPVLTKAATSGILSALGNFLAQMIEKKRKKENSRSLDVGGPLRY AVYGFFFTGPLSHFFYFFMEHWIPPEVPLAGLRRLLLDRLVFAPAFLMLFFLIMNFLEGKDASAFAAKMRGGFWPALRMNWRVWTPLQFI NINYVPLKTFPSSNESRQCPNARCQFAFYGGESGYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWALRKPDDLPAFPLFSA FGRALRYHTGSLAFGALILAIVQIIRVILEYLDQRLKAAENKFAKCLMTCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFCTSARNAFFL LMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVPILTVIVGSYLIAHGFFSVYGMCVDTLFLCFLE -------------------------------------------------------------- >In-frame_ENST00000317479_ENST00000335757_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(transcript)=2646nt_BP=584nt GGGCTCCGCGCCCGGCCAGCCTGAGGTGGGGTCGGTGCCCCCGGCGGCACGGCGCTGGGGAGGCGATGGCGCCGGCCGCGTCCAGGCTGC GGGCCGAAGCCGGGCTCGGGGCGCTGCCGCGGCGGGCGCTCGCCCAGTACCTGCTCTTCCTGCGGCTCTACCCGGTGCTCACCAAGGCGG CCACCAGTGGCATTTTGTCAGCACTTGGGAACTTCCTGGCCCAGATGATTGAGAAGAAGCGGAAAAAAGAAAACTCTAGAAGTCTGGATG TCGGTGGGCCTCTGAGATATGCCGTTTACGGGTTCTTCTTCACAGGGCCGCTGAGTCACTTCTTCTACTTCTTCATGGAACATTGGATCC CTCCTGAGGTCCCCCTGGCAGGGCTCAGGAGGCTTCTCCTGGACCGCCTCGTCTTTGCACCGGCCTTCCTCATGTTGTTCTTCCTCATCA TGAACTTTCTGGAGGGGAAAGACGCCTCAGCCTTCGCCGCCAAGATGAGGGGGGGCTTCTGGCCGGCGCTGAGGATGAACTGGCGGGTGT GGACGCCACTACAGTTCATCAACATCAACTACGTCCCTCTGAAGACCTTCCCCTCCTCCAATGAGTCCCGCCAATGCCCCAATGCCCGTT GCCAGTTCGCCTTCTACGGTGGTGAGTCGGGCTACCACCGGGCCCTGCTGGGCCTGCAGATCTTCAATGCCTTCATGTTCTTCTGGTTGG CCAACTTCGTGCTGGCGCTGGGCCAGGTCACGCTGGCCGGGGCCTTTGCCTCCTACTACTGGGCCCTGCGCAAGCCGGACGACCTGCCGG CCTTCCCGCTCTTCTCTGCCTTTGGCCGGGCGCTCAGGTACCACACAGGCTCCCTGGCCTTTGGCGCGCTCATCCTGGCCATTGTGCAGA TCATCCGTGTGATACTCGAGTACCTGGATCAGCGGCTGAAAGCTGCAGAGAACAAGTTTGCCAAGTGCCTCATGACCTGTCTCAAATGCT GCTTCTGGTGCCTGGAGAAGTTCATCAAATTCCTTAATAGGAATGCCTACATCATGATTGCCATCTACGGCACCAATTTCTGCACCTCGG CCAGGAATGCCTTCTTCCTGCTCATGAGAAACATCATCAGAGTGGCTGTCCTGGATAAAGTTACTGACTTCCTCTTCCTGTTGGGCAAAC TTCTGATCGTTGGTAGTGTGGGGATCCTGGCTTTCTTCTTCTTCACCCACCGTATCAGGATCGTGCAGGATACAGCACCACCCCTCAATT ATTACTGGGTTCCTATACTGACGGTGATCGTTGGCTCCTACTTGATTGCACACGGTTTCTTCAGCGTCTATGGCATGTGTGTGGACACGC TGTTCCTCTGCTTCTTGGAGGACCTGGAGAGGAATGACGGCTCGGCCGAGAGGCCTTACTTCATGTCTTCCACCCTCAAGAAACTCTTGA ACAAGACCAACAAGAAGGCAGCGGAGTCCTGAAGGCCCCGTGCTCCCCACCTCTCAAGGAGTCTCATGCCGCAGGGTGCTCAGTAGCTGG GTCTGTTCCCCCAGCCCCTTGGGCTCACCTGAAGTCCTATCACTGCCGCTCTGCCCCTCCCCATGAGCCAGATCCCACCAGTTTCTGGAC GTGGAGAGTCTGGGGCATCTCCTTCTTATGCCAAGGGGCGCTTGGAGTTTTCATGGCTGCCCCTCCAGACTGCGAGAAACAAGTAAAAAC CCATTGGGGCCTCTTGATGTCTGGGATGGCACGTGGCCCGACCTCCACAAGCTCCCTCATGCTTCCTGTCCCCCGCTTACACGACAACGG GCCAGACCACAGGAAGGACGGTGTTTGTGTCTGAGGGAGCTGCTGGCCACAGTGAACACCCACGTTTATTCCTGCCTGCTCCGGCCAGGA CTGAACCCCTTCTCCACACCTGAACAGTTGGCTCAAGGGCCACCAGAAGCATTTCTTTATTATTATTATTTTTTAACCTGGACATGCATT AAAGGGTCTATTAGCTTTCTTTCCGTCTGTCTCAACAGCTGAGATGGGGCCGCCAAGGAGTGCCTTCCTTTTGCTCCCTCCTAGCTGGGA GTGACGGGTGGGAGTGTGTGTGCCCAGGTGGGGGTGTCTCCTGGCTGGGAAGGAGGGAAAGGGAGGGAGAGTTTTGCGGGGGTTGGCAGT GGAGAGCAGGCTGGAGAGGAGATGGCTAATAGCTGTTTAATGGAAACCTGCTGGGCTGGAGGGAGTTAGGCTGAATTTCCCGACTTCCTC TGCCAGTTATTGACACAGCTCTCTTTGTAAGAGAGGAAAGAAACTAAACCCACCCAAGGGATGATGTCAGGGGGAGAGGTGGAGGGCAGA TGTCCTGGGCAAACCGGGCCCCTCTGCCCACACACCTCACTTGATCCTTTTGCCAAACTTGTCAAACTCAGGGGAACTGGCTTCCCAGTT GCCCCTTTGCCATATTCCAAGTCCCCCTCAGACTTCATGTCTCTGCTCATCAGCACTGTCCCAGGATCCTGGAGAGGGAGAACTCCTGGC CCCAGGGGAAAGAGGGGGGGGTCTCCCGTTTCCTGTGCCTGCACCAGCCCTGCCCCCATTGCGTCTGCACACCCCTGCGTGTAACTGCAT >In-frame_ENST00000317479_ENST00000335757_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(amino acids)=483AA_start in transcript=20_stop in transcript=1471 MRWGRCPRRHGAGEAMAPAASRLRAEAGLGALPRRALAQYLLFLRLYPVLTKAATSGILSALGNFLAQMIEKKRKKENSRSLDVGGPLRY AVYGFFFTGPLSHFFYFFMEHWIPPEVPLAGLRRLLLDRLVFAPAFLMLFFLIMNFLEGKDASAFAAKMRGGFWPALRMNWRVWTPLQFI NINYVPLKTFPSSNESRQCPNARCQFAFYGGESGYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWALRKPDDLPAFPLFSA FGRALRYHTGSLAFGALILAIVQIIRVILEYLDQRLKAAENKFAKCLMTCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFCTSARNAFFL LMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVPILTVIVGSYLIAHGFFSVYGMCVDTLFLCFLE -------------------------------------------------------------- >In-frame_ENST00000317479_ENST00000586078_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(transcript)=3026nt_BP=584nt GGGCTCCGCGCCCGGCCAGCCTGAGGTGGGGTCGGTGCCCCCGGCGGCACGGCGCTGGGGAGGCGATGGCGCCGGCCGCGTCCAGGCTGC GGGCCGAAGCCGGGCTCGGGGCGCTGCCGCGGCGGGCGCTCGCCCAGTACCTGCTCTTCCTGCGGCTCTACCCGGTGCTCACCAAGGCGG CCACCAGTGGCATTTTGTCAGCACTTGGGAACTTCCTGGCCCAGATGATTGAGAAGAAGCGGAAAAAAGAAAACTCTAGAAGTCTGGATG TCGGTGGGCCTCTGAGATATGCCGTTTACGGGTTCTTCTTCACAGGGCCGCTGAGTCACTTCTTCTACTTCTTCATGGAACATTGGATCC CTCCTGAGGTCCCCCTGGCAGGGCTCAGGAGGCTTCTCCTGGACCGCCTCGTCTTTGCACCGGCCTTCCTCATGTTGTTCTTCCTCATCA TGAACTTTCTGGAGGGGAAAGACGCCTCAGCCTTCGCCGCCAAGATGAGGGGGGGCTTCTGGCCGGCGCTGAGGATGAACTGGCGGGTGT GGACGCCACTACAGTTCATCAACATCAACTACGTCCCTCTGAAGACCTTCCCCTCCTCCAATGAGTCCCGCCAATGCCCCAATGCCCGTT GCCAGTTCGCCTTCTACGGTGGTGAGTCGGGCTACCACCGGGCCCTGCTGGGCCTGCAGATCTTCAATGCCTTCATGTTCTTCTGGTTGG CCAACTTCGTGCTGGCGCTGGGCCAGGTCACGCTGGCCGGGGCCTTTGCCTCCTACTACTGGGCCCTGCGCAAGCCGGACGACCTGCCGG CCTTCCCGCTCTTCTCTGCCTTTGGCCGGGCGCTCAGGTACCACACAGGCTCCCTGGCCTTTGGCGCGCTCATCCTGGCCATTGTGCAGA TCATCCGTGTGATACTCGAGTACCTGGATCAGCGGCTGAAAGCTGCAGAGAACAAGTTTGCCAAGTGCCTCATGACCTGTCTCAAATGCT GCTTCTGGTGCCTGGAGAAGTTCATCAAATTCCTTAATAGGAATGCCTACATCATGATTGCCATCTACGGCACCAATTTCTGCACCTCGG CCAGGAATGCCTTCTTCCTGCTCATGAGAAACATCATCAGAGTGGCTGTCCTGGATAAAGTTACTGACTTCCTCTTCCTGTTGGGCAAAC TTCTGATCGTTGGTAGTGTGGGGATCCTGGCTTTCTTCTTCTTCACCCACCGTATCAGGATCGTGCAGGATACAGCACCACCCCTCAATT ATTACTGGGTTCCTATACTGACGGTGATCGTTGGCTCCTACTTGATTGCACACGGTTTCTTCAGCGTCTATGGCATGTGTGTGGACACGC TGTTCCTCTGCTTCTGTGAGGACCTGGAAAGGAATGACGGCTCTCAGGAGCGACCCTACTTCATGTCGCCCGAGCTGAGAGACATCCTGT TGAAGGGGAGTGCGGAGGAGGGGAAGCGGGCAGAAGCCGAGGAGTAGAGAGTGAGGGAGACTGGCGTGGGGGCCAGGTTTCCTCCATGTA GACTGGGGGTGCATGAAGCGGGGGGGTTCCTGGCCTGCGAGTGTGGGGATCCTGTGTGTCCCTCGGAGCCCACTACAGTCTGCCCCTCTC TGGTCCCAGTGTGTCTGCTTTCTAACCCTCTGAGGCTTCTCTGTGACCCTCATCCACCTACCCTGTCCTTGAGGCCCCTGCCCGTGGGCT CCCCTCATGCCTCCTGCTCTGGGACCTCTCTCCACAGTGGAGGACCTGGAGAGGAATGACGGCTCGGCCGAGAGGCCTTACTTCATGTCT TCCACCCTCAAGAAACTCTTGAACAAGACCAACAAGAAGGCAGCGGAGTCCTGAAGGCCCCGTGCTCCCCACCTCTCAAGGAGTCTCATG CCGCAGGGTGCTCAGTAGCTGGGTCTGTTCCCCCAGCCCCTTGGGCTCACCTGAAGTCCTATCACTGCCGCTCTGCCCCTCCCCATGAGC CAGATCCCACCAGTTTCTGGACGTGGAGAGTCTGGGGCATCTCCTTCTTATGCCAAGGGGCGCTTGGAGTTTTCATGGCTGCCCCTCCAG ACTGCGAGAAACAAGTAAAAACCCATTGGGGCCTCTTGATGTCTGGGATGGCACGTGGCCCGACCTCCACAAGCTCCCTCATGCTTCCTG TCCCCCGCTTACACGACAACGGGCCAGACCACAGGAAGGACGGTGTTTGTGTCTGAGGGAGCTGCTGGCCACAGTGAACACCCACGTTTA TTCCTGCCTGCTCCGGCCAGGACTGAACCCCTTCTCCACACCTGAACAGTTGGCTCAAGGGCCACCAGAAGCATTTCTTTATTATTATTA TTTTTTAACCTGGACATGCATTAAAGGGTCTATTAGCTTTCTTTCCGTCTGTCTCAACAGCTGAGATGGGGCCGCCAAGGAGTGCCTTCC TTTTGCTCCCTCCTAGCTGGGAGTGACGGGTGGGAGTGTGTGTGCCCAGGTGGGGGTGTCTCCTGGCTGGGAAGGAGGGAAAGGGAGGGA GAGTTTTGCGGGGGTTGGCAGTGGAGAGCAGGCTGGAGAGGAGATGGCTAATAGCTGTTTAATGGAAACCTGCTGGGCTGGAGGGAGTTA GGCTGAATTTCCCGACTTCCTCTGCCAGTTATTGACACAGCTCTCTTTGTAAGAGAGGAAAGAAACTAAACCCACCCAAGGGATGATGTC AGGGGGAGAGGTGGAGGGCAGATGTCCTGGGCAAACCGGGCCCCTCTGCCCACACACCTCACTTGATCCTTTTGCCAAACTTGTCAAACT CAGGGGAACTGGCTTCCCAGTTGCCCCTTTGCCATATTCCAAGTCCCCCTCAGACTTCATGTCTCTGCTCATCAGCACTGTCCCAGGATC CTGGAGAGGGAGAACTCCTGGCCCCAGGGGAAAGAGGGGGGGGTCTCCCGTTTCCTGTGCCTGCACCAGCCCTGCCCCCATTGCGTCTGC >In-frame_ENST00000317479_ENST00000586078_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(amino acids)=488AA_start in transcript=20_stop in transcript=1486 MRWGRCPRRHGAGEAMAPAASRLRAEAGLGALPRRALAQYLLFLRLYPVLTKAATSGILSALGNFLAQMIEKKRKKENSRSLDVGGPLRY AVYGFFFTGPLSHFFYFFMEHWIPPEVPLAGLRRLLLDRLVFAPAFLMLFFLIMNFLEGKDASAFAAKMRGGFWPALRMNWRVWTPLQFI NINYVPLKTFPSSNESRQCPNARCQFAFYGGESGYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWALRKPDDLPAFPLFSA FGRALRYHTGSLAFGALILAIVQIIRVILEYLDQRLKAAENKFAKCLMTCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFCTSARNAFFL LMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVPILTVIVGSYLIAHGFFSVYGMCVDTLFLCFCE -------------------------------------------------------------- >In-frame_ENST00000428960_ENST00000407327_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(transcript)=2399nt_BP=346nt GCGGAAAAAAGAAAACTCTAGAAGTCTGGATGTCGGTGGGCCTCTGAGATATGCCGTTTACGGGTTCTTCTTCACAGGGCCGCTGAGTCA CTTCTTCTACTTCTTCATGGAACATTGGATCCCTCCTGAGGTCCCCCTGGCAGGGCTCAGGAGGCTTCTCCTGGACCGCCTCGTCTTTGC ACCGGCCTTCCTCATGTTGTTCTTCCTCATCATGAACTTTCTGGAGGGGAAAGACGCCTCAGCCTTCGCCGCCAAGATGAGGGGGGGCTT CTGGCCGGCGCTGAGGATGAACTGGCGGGTGTGGACGCCACTACAGTTCATCAACATCAACTACGTCCCTCTGAAGACCTTCCCCTCCTC CAATGAGTCCCGCCAATGCCCCAATGCCCGTTGCCAGTTCGCCTTCTACGGTGGTGAGTCGGGCTACCACCGGGCCCTGCTGGGCCTGCA GATCTTCAATGCCTTCATGTTCTTCTGGTTGGCCAACTTCGTGCTGGCGCTGGGCCAGGTCACGCTGGCCGGGGCCTTTGCCTCCTACTA CTGGGCCCTGCGCAAGCCGGACGACCTGCCGGCCTTCCCGCTCTTCTCTGCCTTTGGCCGGGCGCTCAGGTACCACACAGGCTCCCTGGC CTTTGGCGCGCTCATCCTGGCCATTGTGCAGATCATCCGTGTGATACTCGAGTACCTGGATCAGCGGCTGAAAGCTGCAGAGAACAAGTT TGCCAAGTGCCTCATGACCTGTCTCAAATGCTGCTTCTGGTGCCTGGAGAAGTTCATCAAATTCCTTAATAGGAATGCCTACATCATGAT TGCCATCTACGGCACCAATTTCTGCACCTCGGCCAGGAATGCCTTCTTCCTGCTCATGAGAAACATCATCAGAGTGGCTGTCCTGGATAA AGTTACTGACTTCCTCTTCCTGTTGGGCAAACTTCTGATCGTTGGTAGTGTGGGGATCCTGGCTTTCTTCTTCTTCACCCACCGTATCAG GATCGTGCAGGATACAGCACCACCCCTCAATTATTACTGGGTTCCTATACTGACGGTGATCGTTGGCTCCTACTTGATTGCACACGGTTT CTTCAGCGTCTATGGCATGTGTGTGGACACGCTGTTCCTCTGCTTCTTGGAGGACCTGGAGAGGAATGACGGCTCGGCCGAGAGGCCTTA CTTCATGTCTTCCACCCTCAAGAAACTCTTGAACAAGACCAACAAGAAGGCAGCGGAGTCCTGAAGGCCCCGTGCTCCCCACCTCTCAAG GAGTCTCATGCCGCAGGGTGCTCAGTAGCTGGGTCTGTTCCCCCAGCCCCTTGGGCTCACCTGAAGTCCTATCACTGCCGCTCTGCCCCT CCCCATGAGCCAGATCCCACCAGTTTCTGGACGTGGAGAGTCTGGGGCATCTCCTTCTTATGCCAAGGGGCGCTTGGAGTTTTCATGGCT GCCCCTCCAGACTGCGAGAAACAAGTAAAAACCCATTGGGGCCTCTTGATGTCTGGGATGGCACGTGGCCCGACCTCCACAAGCTCCCTC ATGCTTCCTGTCCCCCGCTTACACGACAACGGGCCAGACCACAGGAAGGACGGTGTTTGTGTCTGAGGGAGCTGCTGGCCACAGTGAACA CCCACGTTTATTCCTGCCTGCTCCGGCCAGGACTGAACCCCTTCTCCACACCTGAACAGTTGGCTCAAGGGCCACCAGAAGCATTTCTTT ATTATTATTATTTTTTAACCTGGACATGCATTAAAGGGTCTATTAGCTTTCTTTCCGTCTGTCTCAACAGCTGAGATGGGGCCGCCAAGG AGTGCCTTCCTTTTGCTCCCTCCTAGCTGGGAGTGACGGGTGGGAGTGTGTGTGCCCAGGTGGGGGTGTCTCCTGGCTGGGAAGGAGGGA AAGGGAGGGAGAGTTTTGCGGGGGTTGGCAGTGGAGAGCAGGCTGGAGAGGAGATGGCTAATAGCTGTTTAATGGAAACCTGCTGGGCTG GAGGGAGTTAGGCTGAATTTCCCGACTTCCTCTGCCAGTTATTGACACAGCTCTCTTTGTAAGAGAGGAAAGAAACTAAACCCACCCAAG GGATGATGTCAGGGGGAGAGGTGGAGGGCAGATGTCCTGGGCAAACCGGGCCCCTCTGCCCACACACCTCACTTGATCCTTTTGCCAAAC TTGTCAAACTCAGGGGAACTGGCTTCCCAGTTGCCCCTTTGCCATATTCCAAGTCCCCCTCAGACTTCATGTCTCTGCTCATCAGCACTG TCCCAGGATCCTGGAGAGGGAGAACTCCTGGCCCCAGGGGAAAGAGGGGGGGGTCTCCCGTTTCCTGTGCCTGCACCAGCCCTGCCCCCA >In-frame_ENST00000428960_ENST00000407327_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(amino acids)=402AA_start in transcript=25_stop in transcript=1233 MDVGGPLRYAVYGFFFTGPLSHFFYFFMEHWIPPEVPLAGLRRLLLDRLVFAPAFLMLFFLIMNFLEGKDASAFAAKMRGGFWPALRMNW RVWTPLQFININYVPLKTFPSSNESRQCPNARCQFAFYGGESGYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWALRKPDD LPAFPLFSAFGRALRYHTGSLAFGALILAIVQIIRVILEYLDQRLKAAENKFAKCLMTCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFC TSARNAFFLLMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVPILTVIVGSYLIAHGFFSVYGMCV -------------------------------------------------------------- >In-frame_ENST00000428960_ENST00000335757_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(transcript)=2408nt_BP=346nt GCGGAAAAAAGAAAACTCTAGAAGTCTGGATGTCGGTGGGCCTCTGAGATATGCCGTTTACGGGTTCTTCTTCACAGGGCCGCTGAGTCA CTTCTTCTACTTCTTCATGGAACATTGGATCCCTCCTGAGGTCCCCCTGGCAGGGCTCAGGAGGCTTCTCCTGGACCGCCTCGTCTTTGC ACCGGCCTTCCTCATGTTGTTCTTCCTCATCATGAACTTTCTGGAGGGGAAAGACGCCTCAGCCTTCGCCGCCAAGATGAGGGGGGGCTT CTGGCCGGCGCTGAGGATGAACTGGCGGGTGTGGACGCCACTACAGTTCATCAACATCAACTACGTCCCTCTGAAGACCTTCCCCTCCTC CAATGAGTCCCGCCAATGCCCCAATGCCCGTTGCCAGTTCGCCTTCTACGGTGGTGAGTCGGGCTACCACCGGGCCCTGCTGGGCCTGCA GATCTTCAATGCCTTCATGTTCTTCTGGTTGGCCAACTTCGTGCTGGCGCTGGGCCAGGTCACGCTGGCCGGGGCCTTTGCCTCCTACTA CTGGGCCCTGCGCAAGCCGGACGACCTGCCGGCCTTCCCGCTCTTCTCTGCCTTTGGCCGGGCGCTCAGGTACCACACAGGCTCCCTGGC CTTTGGCGCGCTCATCCTGGCCATTGTGCAGATCATCCGTGTGATACTCGAGTACCTGGATCAGCGGCTGAAAGCTGCAGAGAACAAGTT TGCCAAGTGCCTCATGACCTGTCTCAAATGCTGCTTCTGGTGCCTGGAGAAGTTCATCAAATTCCTTAATAGGAATGCCTACATCATGAT TGCCATCTACGGCACCAATTTCTGCACCTCGGCCAGGAATGCCTTCTTCCTGCTCATGAGAAACATCATCAGAGTGGCTGTCCTGGATAA AGTTACTGACTTCCTCTTCCTGTTGGGCAAACTTCTGATCGTTGGTAGTGTGGGGATCCTGGCTTTCTTCTTCTTCACCCACCGTATCAG GATCGTGCAGGATACAGCACCACCCCTCAATTATTACTGGGTTCCTATACTGACGGTGATCGTTGGCTCCTACTTGATTGCACACGGTTT CTTCAGCGTCTATGGCATGTGTGTGGACACGCTGTTCCTCTGCTTCTTGGAGGACCTGGAGAGGAATGACGGCTCGGCCGAGAGGCCTTA CTTCATGTCTTCCACCCTCAAGAAACTCTTGAACAAGACCAACAAGAAGGCAGCGGAGTCCTGAAGGCCCCGTGCTCCCCACCTCTCAAG GAGTCTCATGCCGCAGGGTGCTCAGTAGCTGGGTCTGTTCCCCCAGCCCCTTGGGCTCACCTGAAGTCCTATCACTGCCGCTCTGCCCCT CCCCATGAGCCAGATCCCACCAGTTTCTGGACGTGGAGAGTCTGGGGCATCTCCTTCTTATGCCAAGGGGCGCTTGGAGTTTTCATGGCT GCCCCTCCAGACTGCGAGAAACAAGTAAAAACCCATTGGGGCCTCTTGATGTCTGGGATGGCACGTGGCCCGACCTCCACAAGCTCCCTC ATGCTTCCTGTCCCCCGCTTACACGACAACGGGCCAGACCACAGGAAGGACGGTGTTTGTGTCTGAGGGAGCTGCTGGCCACAGTGAACA CCCACGTTTATTCCTGCCTGCTCCGGCCAGGACTGAACCCCTTCTCCACACCTGAACAGTTGGCTCAAGGGCCACCAGAAGCATTTCTTT ATTATTATTATTTTTTAACCTGGACATGCATTAAAGGGTCTATTAGCTTTCTTTCCGTCTGTCTCAACAGCTGAGATGGGGCCGCCAAGG AGTGCCTTCCTTTTGCTCCCTCCTAGCTGGGAGTGACGGGTGGGAGTGTGTGTGCCCAGGTGGGGGTGTCTCCTGGCTGGGAAGGAGGGA AAGGGAGGGAGAGTTTTGCGGGGGTTGGCAGTGGAGAGCAGGCTGGAGAGGAGATGGCTAATAGCTGTTTAATGGAAACCTGCTGGGCTG GAGGGAGTTAGGCTGAATTTCCCGACTTCCTCTGCCAGTTATTGACACAGCTCTCTTTGTAAGAGAGGAAAGAAACTAAACCCACCCAAG GGATGATGTCAGGGGGAGAGGTGGAGGGCAGATGTCCTGGGCAAACCGGGCCCCTCTGCCCACACACCTCACTTGATCCTTTTGCCAAAC TTGTCAAACTCAGGGGAACTGGCTTCCCAGTTGCCCCTTTGCCATATTCCAAGTCCCCCTCAGACTTCATGTCTCTGCTCATCAGCACTG TCCCAGGATCCTGGAGAGGGAGAACTCCTGGCCCCAGGGGAAAGAGGGGGGGGTCTCCCGTTTCCTGTGCCTGCACCAGCCCTGCCCCCA >In-frame_ENST00000428960_ENST00000335757_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(amino acids)=402AA_start in transcript=25_stop in transcript=1233 MDVGGPLRYAVYGFFFTGPLSHFFYFFMEHWIPPEVPLAGLRRLLLDRLVFAPAFLMLFFLIMNFLEGKDASAFAAKMRGGFWPALRMNW RVWTPLQFININYVPLKTFPSSNESRQCPNARCQFAFYGGESGYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWALRKPDD LPAFPLFSAFGRALRYHTGSLAFGALILAIVQIIRVILEYLDQRLKAAENKFAKCLMTCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFC TSARNAFFLLMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVPILTVIVGSYLIAHGFFSVYGMCV -------------------------------------------------------------- >In-frame_ENST00000428960_ENST00000586078_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(transcript)=2788nt_BP=346nt GCGGAAAAAAGAAAACTCTAGAAGTCTGGATGTCGGTGGGCCTCTGAGATATGCCGTTTACGGGTTCTTCTTCACAGGGCCGCTGAGTCA CTTCTTCTACTTCTTCATGGAACATTGGATCCCTCCTGAGGTCCCCCTGGCAGGGCTCAGGAGGCTTCTCCTGGACCGCCTCGTCTTTGC ACCGGCCTTCCTCATGTTGTTCTTCCTCATCATGAACTTTCTGGAGGGGAAAGACGCCTCAGCCTTCGCCGCCAAGATGAGGGGGGGCTT CTGGCCGGCGCTGAGGATGAACTGGCGGGTGTGGACGCCACTACAGTTCATCAACATCAACTACGTCCCTCTGAAGACCTTCCCCTCCTC CAATGAGTCCCGCCAATGCCCCAATGCCCGTTGCCAGTTCGCCTTCTACGGTGGTGAGTCGGGCTACCACCGGGCCCTGCTGGGCCTGCA GATCTTCAATGCCTTCATGTTCTTCTGGTTGGCCAACTTCGTGCTGGCGCTGGGCCAGGTCACGCTGGCCGGGGCCTTTGCCTCCTACTA CTGGGCCCTGCGCAAGCCGGACGACCTGCCGGCCTTCCCGCTCTTCTCTGCCTTTGGCCGGGCGCTCAGGTACCACACAGGCTCCCTGGC CTTTGGCGCGCTCATCCTGGCCATTGTGCAGATCATCCGTGTGATACTCGAGTACCTGGATCAGCGGCTGAAAGCTGCAGAGAACAAGTT TGCCAAGTGCCTCATGACCTGTCTCAAATGCTGCTTCTGGTGCCTGGAGAAGTTCATCAAATTCCTTAATAGGAATGCCTACATCATGAT TGCCATCTACGGCACCAATTTCTGCACCTCGGCCAGGAATGCCTTCTTCCTGCTCATGAGAAACATCATCAGAGTGGCTGTCCTGGATAA AGTTACTGACTTCCTCTTCCTGTTGGGCAAACTTCTGATCGTTGGTAGTGTGGGGATCCTGGCTTTCTTCTTCTTCACCCACCGTATCAG GATCGTGCAGGATACAGCACCACCCCTCAATTATTACTGGGTTCCTATACTGACGGTGATCGTTGGCTCCTACTTGATTGCACACGGTTT CTTCAGCGTCTATGGCATGTGTGTGGACACGCTGTTCCTCTGCTTCTGTGAGGACCTGGAAAGGAATGACGGCTCTCAGGAGCGACCCTA CTTCATGTCGCCCGAGCTGAGAGACATCCTGTTGAAGGGGAGTGCGGAGGAGGGGAAGCGGGCAGAAGCCGAGGAGTAGAGAGTGAGGGA GACTGGCGTGGGGGCCAGGTTTCCTCCATGTAGACTGGGGGTGCATGAAGCGGGGGGGTTCCTGGCCTGCGAGTGTGGGGATCCTGTGTG TCCCTCGGAGCCCACTACAGTCTGCCCCTCTCTGGTCCCAGTGTGTCTGCTTTCTAACCCTCTGAGGCTTCTCTGTGACCCTCATCCACC TACCCTGTCCTTGAGGCCCCTGCCCGTGGGCTCCCCTCATGCCTCCTGCTCTGGGACCTCTCTCCACAGTGGAGGACCTGGAGAGGAATG ACGGCTCGGCCGAGAGGCCTTACTTCATGTCTTCCACCCTCAAGAAACTCTTGAACAAGACCAACAAGAAGGCAGCGGAGTCCTGAAGGC CCCGTGCTCCCCACCTCTCAAGGAGTCTCATGCCGCAGGGTGCTCAGTAGCTGGGTCTGTTCCCCCAGCCCCTTGGGCTCACCTGAAGTC CTATCACTGCCGCTCTGCCCCTCCCCATGAGCCAGATCCCACCAGTTTCTGGACGTGGAGAGTCTGGGGCATCTCCTTCTTATGCCAAGG GGCGCTTGGAGTTTTCATGGCTGCCCCTCCAGACTGCGAGAAACAAGTAAAAACCCATTGGGGCCTCTTGATGTCTGGGATGGCACGTGG CCCGACCTCCACAAGCTCCCTCATGCTTCCTGTCCCCCGCTTACACGACAACGGGCCAGACCACAGGAAGGACGGTGTTTGTGTCTGAGG GAGCTGCTGGCCACAGTGAACACCCACGTTTATTCCTGCCTGCTCCGGCCAGGACTGAACCCCTTCTCCACACCTGAACAGTTGGCTCAA GGGCCACCAGAAGCATTTCTTTATTATTATTATTTTTTAACCTGGACATGCATTAAAGGGTCTATTAGCTTTCTTTCCGTCTGTCTCAAC AGCTGAGATGGGGCCGCCAAGGAGTGCCTTCCTTTTGCTCCCTCCTAGCTGGGAGTGACGGGTGGGAGTGTGTGTGCCCAGGTGGGGGTG TCTCCTGGCTGGGAAGGAGGGAAAGGGAGGGAGAGTTTTGCGGGGGTTGGCAGTGGAGAGCAGGCTGGAGAGGAGATGGCTAATAGCTGT TTAATGGAAACCTGCTGGGCTGGAGGGAGTTAGGCTGAATTTCCCGACTTCCTCTGCCAGTTATTGACACAGCTCTCTTTGTAAGAGAGG AAAGAAACTAAACCCACCCAAGGGATGATGTCAGGGGGAGAGGTGGAGGGCAGATGTCCTGGGCAAACCGGGCCCCTCTGCCCACACACC TCACTTGATCCTTTTGCCAAACTTGTCAAACTCAGGGGAACTGGCTTCCCAGTTGCCCCTTTGCCATATTCCAAGTCCCCCTCAGACTTC ATGTCTCTGCTCATCAGCACTGTCCCAGGATCCTGGAGAGGGAGAACTCCTGGCCCCAGGGGAAAGAGGGGGGGGTCTCCCGTTTCCTGT >In-frame_ENST00000428960_ENST00000586078_TCGA-27-2524-01A_PXMP2_chr12_133277955_+_SLC44A2_chr19_10746999_length(amino acids)=407AA_start in transcript=25_stop in transcript=1248 MDVGGPLRYAVYGFFFTGPLSHFFYFFMEHWIPPEVPLAGLRRLLLDRLVFAPAFLMLFFLIMNFLEGKDASAFAAKMRGGFWPALRMNW RVWTPLQFININYVPLKTFPSSNESRQCPNARCQFAFYGGESGYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWALRKPDD LPAFPLFSAFGRALRYHTGSLAFGALILAIVQIIRVILEYLDQRLKAAENKFAKCLMTCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFC TSARNAFFLLMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVPILTVIVGSYLIAHGFFSVYGMCV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PXMP2-SLC44A2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PXMP2-SLC44A2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PXMP2-SLC44A2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | SLC44A2 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |